Mycobacterium leprae as an Opportunistic Pathogen

[1]  Harjinder Singh.  Heat stability of milk , 2004 .

[2]  D. Hwang,et al.  Effects of essential fatty acid deficiency on prostaglandin E2 production and cell-mediated immunity in a mouse model of leprosy , 1997, Infection and immunity.

[3]  L. Adams,et al.  Granulomas Induced byMycobacterium leprae , 1996 .

[4]  B. Ji,et al.  Bactericidal activities of combinations of new drugs against Mycobacterium leprae in nude mice , 1996, Antimicrobial agents and chemotherapy.

[5]  P. Fine,et al.  Eliminating leprosy as a public health problem--is the optimism justified? , 1996, World health forum.

[6]  J. Grimwood.  Microbes as tools for cell biology: edited by David G. Russell, Academic Press, 1994. £35.00 (339 pages) ISBN 0 12 604040 0 , 1995 .

[7]  G. Kaplan,et al.  Cellular immune response to Mycobacterium leprae infection in human immunodeficiency virus-infected individuals , 1995, Infection and Immunity.

[8]  Krahenbuhl Jl,et al.  The role of the macrophage in resistance to the leprosy bacillus. , 1994 .

[9]  D. Russell.  Immunoelectron microscopy of endosomal trafficking in macrophages infected with microbial pathogens. , 1994, Methods in cell biology.

[10]  L. Adams,et al.  Regulation of murine macrophage effector functions by lipoarabinomannan from mycobacterial strains with different degrees of virulence , 1993, Infection and immunity.

[11]  B. Zwilling,et al.  Macrophage-Pathogen Interactions , 1993 .

[12]  J. Ellner,et al.  Mycobacterium avium complex infection and AIDS: advances in theory and practice. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  S. Hart,et al.  Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. , 1992, The Journal of biological chemistry.

[14]  G. Kaplan,et al.  Prolonged treatment with recombinant interferon gamma induces erythema nodosum leprosum in lepromatous leprosy patients , 1992, The Journal of experimental medicine.

[15]  G. Schoolnik,et al.  An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms. , 1992, The New England journal of medicine.

[16]  K. Weinberg,et al.  Defining protective responses to pathogens: cytokine profiles in leprosy lesions. , 1991, Science.

[17]  L. Sibley,et al.  Tumor necrosis factor-alpha triggers antitoxoplasmal activity of IFN-gamma primed macrophages. , 1991, Journal of immunology.

[18]  S. Franzblau,et al.  L-arginine-dependent macrophage effector functions inhibit metabolic activity of Mycobacterium leprae. , 1991, Journal of immunology.

[19]  L. Adams,et al.  Effects of activated macrophages on Mycobacterium leprae , 1991, Infection and immunity.

[20]  J. Sterne,et al.  Is HIV infection a risk factor for leprosy? , 1991, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

[21]  G. Kaplan,et al.  The systemic influence of recombinant interleukin 2 on the manifestations of lepromatous leprosy , 1991, The Journal of experimental medicine.

[22]  J. Avelleira,et al.  Leprosy as cause of false-positive results in serological assays for the detection of antibodies to HIV-1. , 1991, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

[23]  G. Rook,et al.  New insights into the immunopathology of tuberculosis. , 1991, Pathobiology : journal of immunopathology, molecular and cellular biology.

[24]  C. K. Job,et al.  New findings on the mode of entry of Mycobacterium leprae in nude mice. , 1990, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

[25]  L. Sibley,et al.  Gamma interferon in experimental leprosy. , 1990, Diagnostic microbiology and infectious disease.

[26]  L. Sibley,et al.  Inhibition of interferon‐gamma‐mediated activation in mouse macrophages treated with lipoarabinomannan , 1990, Clinical and experimental immunology.

[27]  R. Thorpe,et al.  Failure to detect antibodies to HIV-1 in sera from patients with mycobacterial infections. , 1989, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

[28]  G. Kaplan,et al.  Effect of multiple interferon gamma injections on the disposal of Mycobacterium leprae. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[29]  I. Weissman,et al.  Analysis of naturally occurring delayed-type hypersensitivity reactions in leprosy by in situ hybridization , 1989, The Journal of experimental medicine.

[30]  S. Patil,et al.  Antibodies to HIV-1 in sera from patients with mycobacterial infections. , 1988, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

[31]  P. Fine,et al.  Leprosy in Malawi. 2. Background, design and prospects of the Karonga Prevention Trial, a leprosy vaccine trial in northern Malawi. , 1988, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[32]  R. Rees,et al.  AIDS and leprosy. , 1988, Leprosy review.

[33]  L. Sibley,et al.  Induction of unresponsiveness to gamma interferon in macrophages infected with Mycobacterium leprae , 1988, Infection and immunity.

[34]  J. Convit,et al.  Learning from lesions: patterns of tissue inflammation in leprosy. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[35]  L. Sibley,et al.  Defective Activation of Granuloma Macrophages From Mycobacterium leprae‐Infected Nude Mice , 1988, Journal of leukocyte biology.

[36]  G. Rook.  Role of activated macrophages in the immunopathology of tuberculosis. , 1988, British medical bulletin.

[37]  L. Sibley,et al.  Intracellular fate of Mycobacterium leprae in normal and activated mouse macrophages , 1987, Infection and immunity.

[38]  L. Sibley,et al.  Mycobacterium leprae-burdened macrophages are refractory to activation by gamma interferon , 1987, Infection and immunity.

[39]  P. Brennan,et al.  Structure and antigenicity of the phosphorylated lipopolysaccharide antigens from the leprosy and tubercle bacilli. , 1986, The Journal of biological chemistry.

[40]  R. Steinman,et al.  Local and systemic effects of intradermal recombinant interferon-gamma in patients with lepromatous leprosy. , 1986, The New England journal of medicine.

[41]  Lagrange Ph.  Immunogenetics of leprosy , 1986 .

[42]  G. Rook,et al.  Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. , 1986, Immunology.

[43]  C. K. Job,et al.  Transmission of leprosy in nude mice. , 1985, The American journal of tropical medicine and hygiene.

[44]  J. Teruel,et al.  Successful kidney transplantation in leprosy and transitory recurrence of the disease. , 1985, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

[45]  M. Colston,et al.  Infection of the congenitally athymic rat with Mycobacterium leprae. , 1983, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

[46]  C. Taylor,et al.  In situ characterization of T lymphocyte subsets in the reactional states of leprosy. , 1983, Clinical and experimental immunology.

[47]  C. Taylor,et al.  T lymphocyte subsets in the skin lesions of patients with leprosy. , 1983, Journal of the American Academy of Dermatology.

[48]  C. Shepard,et al.  Heat stability of Mycobacterium leprae immunogenicity , 1978, Infection and immunity.

[49]  B. Giovanella,et al.  The Nude Mouse in Experimental and Clinical Research , 1978 .

[50]  R. Hastings.  Growth of Sulfone-Resistant M. leprae in the Foot Pads of Mice Fed Dapsone , 1977, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[51]  R. Rees,et al.  LEPRAE IN MICE , 1977 .

[52]  L. Levy,et al.  Neonatally thymectomized Lewis rats infected with Mycobacterium leprae: response to primary infection, secondary challenge, and large inocula , 1976, Infection and immunity.

[53]  D. Adu,et al.  Renal transplantation in leprosy. , 1973, British medical journal.

[54]  Storrs Ee,et al.  Attempts to establish the Armadillo (Dasypus novemcinctus linn.) as a model for the study of leprosy. II. Histopathologic and bacteriologic post-mortem findings in lepromatoid leprosy in the Armadillo. , 1972 .

[55]  Storrs Ee,et al.  Attempts to establish the armadillo (Dasypus novemcinctus Linn.) as a model for the study of leprosy. I. Report of lepromatoid leprosy in an experimentally infected armadillo. , 1971 .

[56]  Shepard Cc.  A survey of the drugs with activity against M. leprae in mice. , 1971 .

[57]  T. Sabin.  Temperature-linked sensory loss. A unique pattern in leprosy. , 1969, Archives of neurology.

[58]  P W Brand,et al.  Bacterial density in the skin in lepromatous leprosy as related to temperature. , 1968, Leprosy review.

[59]  D. H. McRae,et al.  A method for counting acid-fast bacteria. , 1968, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

[60]  R. Rees,et al.  Experimental Lepromatous Leprosy , 1967, Nature.

[61]  Ridley Ds,et al.  Classification of leprosy according to immunity. A five-group system. , 1966 .

[62]  Robert L. Berger,et al.  An Experimental and Clinical Study , 1966 .

[63]  R. Rees.  SULPHONE RESISTANCE IN LEPROSY. , 1964, Lancet.

[64]  R. Rees,et al.  SULPHONE RESISTANCE IN LEPROSY. AN EXPERIMENTAL AND CLINICAL STUDY. , 1964, Lancet.

[65]  C. Shepard.  THE EXPERIMENTAL DISEASE THAT FOLLOWS THE INJECTION OF HUMAN LEPROSY BACILLI INTO FOOT-PADS OF MICE , 1960, The Journal of experimental medicine.